Category Archives: Agency Specific

New NSF Grants.gov Application Guide

Posted on by

NSF is pleased to announce that a revised version of the NSF Grants.gov Application Guide has been issued.  The NSF Grants.gov Application Guide has been updated to align with changes to NSF’s Proposal & Award Policies & Procedures Guide (PAPPG) (NSF 18-1).  Information about FastLane system registration has been removed and replaced with guidance for registering in Research.gov.  Editorial changes have also been made to either clarify or enhance the intended meaning of a sentence or section or to ensure consistency with data contained in NSF systems or other NSF policy documents.

The new NSF Grants.gov Application Guide will be effective for proposals submitted, or due, on or after January 29, 2018.

If you have any questions regarding these changes, please contact ORA or your Sr. Grants Coordinator.  For technical questions relating to Grants.gov, please contact Grants.gov directly at 1-800-518-4726 or support@grants.gov.

Funding Opportunity – Patient-Centered Outcomes Research Institute (PCORI): Addressing Disparities

Posted on by

We would like to inform you that the Patient-Centered Outcomes Research Institute (PCORI) will be updating the Addressing Disparities Priority Area Research Areas of Interest, within the Broad PCORI Funding Announcement for Cycle 1 2018, with a focus on the following topics:

  • Diagnosis, Initiation of Treatment, and Retention of African Americans and Hispanics/Latinos along the HIV Care Continuum
  • Interventions to Reduce Disparities in Obstructive Sleep Apnea and Insomnia
  • Medication-Assisted Treatment (MAT) Delivery for American Indian/Alaska Native Populations with Opioid Misuse Disorders

The goal of these areas of interest is to support patient-centered clinical effectiveness research (CER) that addresses important questions regarding strategies to improve health and healthcare outcomes for vulnerable populations at risk for experiencing disparities.

Please note that for this Cycle 1 2018 funding announcement, we now have two options for direct costs and maximum project periods. Applicants may submit Letters of Intent for either awards of up to $2 million in direct costs over a maximum period of three years or awards up to $5 million in direct costs over a maximum period of four years.

PCORI’s mission is to improve the quality and relevance of evidence available to help patients, caregivers, clinicians, employers, insurers, and policy makers make informed health decisions. We invite you to review this pre-announcement, available on our website, and share this information with others who may be interested. We also invite you to register for the Town Hall on February 1, 2018. The funding announcement will be released on January 16, 2018. 

Resubmitting Proposals to NIH?

Posted on by

“A few months ago, a researcher told me about his experiences with the relatively new NIH policy by which investigators are allowed to submit what we have come to call “virtual A2s.” Under NIH’s previous single resubmission policy, if an investigator’s de novo R01 grant application (called an “A0”) was not funded, they had one chance to submit a revision (called an “A1”). If the A1 application was unsuccessful, the applicant was required to make significant changes in the application compared to the previous submissions.” Continue reading…

 

New Funding Source for NIH Applicants

Posted on by

“Last year, U.S. researchers received about 42,500 pieces of bad news from the National Institutes of Health (NIH). Their grant proposal had been rejected; they wouldn’t be receiving a piece of the agency’s roughly $30 billion federal funding pie. For many, the next step is to cast around for slices of smaller pies—grants from nonprofit disease foundations or investments from private companies that might keep their projects alive.

Now, a new program aims to play matchmaker between these researchers and second-chance funders. The Online Partnership to Accelerate Research (OnPAR), a collaboration between NIH and the defense, engineering, and health contractor Leidos, lets researchers upload rejected NIH proposals to an online portal where potential funders can review the scores received from reviewers, and decide whether to put up cash.”

Read more online

 

Breast Cancer & ALS Research Programs 2016

Posted on by

Amyotrophic Lateral Sclerosis Research Program

Therapeutic Idea Award

Therapeutic Development Award

Breast Cancer Research Program

Breakthrough Award Levels 1 and 2

Breakthrough Award Levels 3 and 4

Breakthrough Fellowship Award

Distinguished Investigator Award

Era of Hope Scholar Award

Innovator Award

Submission is a two-step process requiring both (1) pre-application submission through the electronic Biomedical Research Application Portal (eBRAP) (https://eBRAP.org/) and (2) application submission through Grants.gov (http://www.grants.gov/).  Refer to the General Application Instructions, Section II.A. for registration and submission requirements for eBRAP and Grants.gov.